Bristol Myers Squibb ROI - Return on Investment 2010-2025 | BMY

Bristol Myers Squibb return on investment for the quarter ending March 31, 2025 was 8.36.

  • Bristol Myers Squibb average return on investment for 2024 was -11.06, a 193.02% decline from 2023.
  • Bristol Myers Squibb average return on investment for 2023 was 11.89, a 32.11% decline from 2022.
  • Bristol Myers Squibb average return on investment for 2022 was 9, a 432.1% increase from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Bristol Myers Squibb ROI - Return on Investment 2010-2025 | BMY

  • Bristol Myers Squibb average return on investment for 2024 was -11.06, a 193.02% decline from 2023.
  • Bristol Myers Squibb average return on investment for 2023 was 11.89, a 32.11% decline from 2022.
  • Bristol Myers Squibb average return on investment for 2022 was 9, a 432.1% increase from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.